Global and regional prevalence and burden for premenstrual syndrome and premenstrual dysphoric disorder

Abstract

Introduction: Premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD) are becoming common mental diseases in women impairing daily functioning. Estimation of the epidemiological burden of PMS/PMDD can serve as scientific basis for prevention and management of premenstrual disorders. Herein, we firstly provide a protocol to perform estimation on the prevalence and risk factors for PMS/PMDD in the general population globally and regionally. Methods/design: The PubMed, Web of Science, Chinese National Knowledge Infrastructure, the Cochrane Central Register of Controlled Trials (Cochrane Library), Chinese VIP Information, EMBASE, Wanfang Database, as well as the Chinese Biomedical Literature Database will be queried to find related studies containing information on the prevalence of PMDD (2011–2021). Two independent reviewers will comb the literature and abstract the data characteristics. Disparities will be reconciled via consents. The primary outcome will be the global prevalence. The random-effect model will be employed to pool the assessments. The standard χ 2 tests, as well as the I 2 statistic will be used to determine heterogeneity. Furthermore, the meta-regression analysis will be employed to estimate the differences in study-level characteristics. All the statistical analyses will be carried out in the software Stata v 15.0 (Stata Corporation, College Station, TX), as well as the R (v R 3.5.1, R Foundation for Statistical Computing, Vienna, Austria) software. Discussion: Based on existing evidence, our study will offer a high-quality synthesis for global and regional prevalence, burden, and risk factors of PMS/PMDD. Effective strategies will be made for prevention and management of epidemiological burden on the PMS/PMDD, even premenstrual disorders. Ethics and dissemination: This study does not involve the specific patients, and all research data comes from publicly available professional literature, so an ethics committee is not required to conduct an ethical review and approval of the study. INPLASY registration number: INPLASY2021120065.

Emerging Perspectives on the Impact of Diabetes Mellitus and Anti-Diabetic Drugs on Premenstrual Syndrome. A Narrative Review

“…Once the symptoms become severe to the point of debilitation, it meets the criteria of premenstrual dysphoric disorder (PMDD). Approximately 20–40% of young women suffer from PMS, 2–8% from PMDD, and 85% suffer from at least one symptom of PMS during their child-bearing years [ 1 , 2 ].…”

Effects of Satureja brevicalyx essential oil inhalation on coping premenstrual syndrome

“…4 Epidemiological data affirm that 90% of females of reproductive age are usually impacted by mild to acute premenstrual symptoms, among them, about 20% to 40% are affected for PMS. 5 Additionally, prevalence among university students is over 50%. 6 Indeed, an investigation found that PMS affects quality of life students, particularly components related to mental and environmental health.…”

Premenstrual Syndrome and Mindfulness: the mediating effect of Perceived Social Support and health-related quality of life among deaf/hard of hearing women

“…This requires her to face different feelings. Many women undergo changes in their bodies or moods, such as depression or weight gain (Gao et al,2022;Zaka& Mahmood,2012). The symptoms get worse during the second half of the menstrual cycle and then fade and go away after the start of the next menstrual cycle.…”